泓博医药(301230.SZ)：目前未与阿里巴巴或其他互联网平台开展C端健康医疗类项目合作
Pharma Resources (Shanghai) Pharma Resources (Shanghai) (SZ:301230) Ge Long Hui·2025-12-22 08:16

Core Viewpoint - Hongbo Pharmaceutical (301230.SZ) emphasizes its focus on new drug research and development services as a CRO, highlighting a significant difference in business model compared to internet companies that provide C-end healthcare services [1] Group 1 - The company has not engaged in C-end health medical project collaborations with Alibaba or other internet platforms [1]